Ignite Creation Date:
2024-07-17 @ 10:55 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06480110
Status:
RECRUITING
Last Update Posted:
2024-06-28
First Post:
2020-11-18
Brief Title:
Ebastine in Combination With Docetaxel as a Treatment for Castration-resistant Metastatic Prostate Cancer
Sponsor:
Rigshospitalet Denmark
Organization:
Rigshospitalet Denmark
Organization Data
Organization:
Rigshospitalet Denmark
Class:
OTHER
Study ID:
Ebas0001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Rigshospitalet Denmark
Lead Sponsor Class:
OTHER
Responsible Party:
Helle Pappot
Responsible Party Title:
Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Rigshospitalet Denmark
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Danish Cancer Society | OTHER |